Trial Profile
Safety and Efficacy of Intraperitoneal Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis Receiving Systemic Chemotherapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Dec 2023
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms IPLUS
- 02 Dec 2023 Status changed from recruiting to completed.
- 22 Jan 2022 Results presented at the 2022 Gastrointestinal Cancers Symposium
- 07 Mar 2021 Planned End Date changed from 31 Dec 2021 to 31 Dec 2023.